LB: New data on safety and efficacy of COVID vaccination
Monday, July 12, 2021
•
S196
•
5:15 PM
>
6:15 PM
•
LB: New data on safety and efficacy of COVID vaccination
•
12a. COVID-19
5:15 PM
•
4722
•
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalised COVID-19 patients in Israel
>
T.
Tal
BROSH-NISSIMOV (Ashdod)
5:25 PM
•
4663
•
Outbreak of SARS-CoV-2 infection in a long-term care facility after full COVID-19 vaccination: risk factors assessment
>
M.
Martin
MARTINOT (Colmar)
5:35 PM
•
4751
•
Global patient safety database analysis: thrombotic events with thrombocytopenia after second dose of COVID-19 vaccine
>
M.
Magnus
NORD (Mölndal)
5:45 PM
•
4826
•
The impact of the BNT162b2 vaccine on kidney transplant and chronic dialysis patients: initial report from the COVID-19 mRNA vaccine immunogenicity in patients with end stage renal disease; the Jerusalem COVIReD Study
>
Y.
Yonatan
OSTER (Jerusalem)
5:55 PM
•
4975
•
Safety of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines
>
E.
Eva P.
GALIZA (London)
6:05 PM
•
INT111
•
Q&A/Discussion
|